Point72 Hong Kong Ltd - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q3 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$10,000
-89.4%
3,017
-42.5%
0.00%
-100.0%
Q3 2021$94,000
-65.4%
5,248
-66.9%
0.00%
-66.7%
Q2 2021$272,000
+13500.0%
15,849
+11553.7%
0.01%
Q4 2020$2,000
-99.6%
136
-99.4%
0.00%
-100.0%
Q2 2020$489,000
+270.5%
21,131
+192.6%
0.05%
+42.1%
Q3 2019$132,000
+1785.7%
7,222
+3212.8%
0.04%
+1166.7%
Q1 2019$7,000
-30.0%
218
+36.2%
0.00%0.0%
Q3 2018$10,000
-52.4%
160
-18.4%
0.00%
-72.7%
Q1 2018$21,000
+200.0%
196
-51.0%
0.01%
+175.0%
Q3 2016$7,0004000.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders